Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
This article has been cited by
1Inflammatory cytokines in bladder cancer
Pejman Shadpour,Mojtaba Zamani,Nazi Aghaalikhani,Nadereh Rashtchizadeh
Journal of Cellular Physiology.2019;234(9)14489
[DOI]
2Serum Levels of Interleukin-6 and Titers of Antibodies against Porphyromonas gingivalis Could Be Potential Biomarkers for the Diagnosis of Oral Squamous Cell Carcinoma
Dae-Gun Park,Bok Hee Woo,Byung-Joo Lee,Sanggyeong Yoon,Youngseuk Cho,Yong-Deok Kim,Hae Ryoun Park,Jae Min Song
International Journal of Molecular Sciences.2019;20(11)2749
[DOI]
3Cytokine Interaction With Cancer-Associated Fibroblasts in Esophageal Cancer
Md Sazzad Hassan,Nicholas Cwidak,Niranjan Awasthi,Urs von Holzen
Cancer Control.2022;29(11)107327482210784
[DOI]
4The immune landscape of esophageal cancer
Tu-Xiong Huang,Li Fu
Cancer Communications.2019;39(1)107327482210784
[DOI]
5The immune landscape of esophageal cancer
Jae Bock Chung,Jae Uk Chong,Jin-Young Choi,Kazuichi Okazaki
Cancer Communications.2020;39(1)307
[DOI]
6Tumor shrinkage rate as a potential marker for the prediction of long-term outcome in advanced non-small cell lung cancer treated with first-line tyrosine kinase inhibitors
Shanshan Yu,Xingchen Wang,Xiaoyan Wang,Xueyuan Wu,Rongrong Xu,Xiaoqi Wang,Xue Zhang,Chunhong Zhang,Kun Chen,Dezhi Cheng,L Wenfeng
Journal of Cancer Research and Therapeutics.2019;15(7)1574
[DOI]
7Tumor shrinkage rate as a potential marker for the prediction of long-term outcome in advanced non-small cell lung cancer treated with first-line tyrosine kinase inhibitors
Jae Bock Chung,Jae Uk Chong
Journal of Cancer Research and Therapeutics.2020;15(7)13
[DOI]
8The inflammatory microenvironment and the urinary microbiome in the initiation and progression of bladder cancer
Xingxing Huang,Ting Pan,Lili Yan,Ting Jin,Ruonan Zhang,Bi Chen,Jiao Feng,Ting Duan,Yu Xiang,Mingming Zhang,Xiaying Chen,Zuyi Yang,Wenzheng Zhang,Xia Ding,Tian Xie,Xinbing Sui
Genes & Diseases.2021;8(6)781
[DOI]
9Role of inflammatory microenvironment: potential implications for improved breast cancer nano-targeted therapy
Meng Lan,Wenping Lu,Tengteng Zou,Lihong Li,Fengjie Liu,Tiange Cai,Yu Cai
Cellular and Molecular Life Sciences.2021;78(5)2105
[DOI]
10Comparison between Heat-Clearing Medicine and Antirheumatic Medicine in Treatment of Gastric Cancer Based on Network Pharmacology, Molecular Docking, and Tumor Immune Infiltration Analysis
Jiamin Xu,Fuqin Kang,Wei Wang,Shujun Liu,Jianhui Xie,Xiaobo Yang,Talha Bin Emran
Evidence-Based Complementary and Alternative Medicine.2022;2022(5)1
[DOI]
11Long non-coding RNA LEISA promotes progression of lung adenocarcinoma via enhancing interaction between STAT3 and IL-6 promoter
Shanshan Wu,Bangdong Liu,Youhong Zhang,Ruohui Hong,Shihua Liu,Tao Xiang,Tianyu Tao,Junchao Cai,Jueheng Wu,Mengfeng Li,Hongyu Guan
Oncogene.2021;40(19)3449
[DOI]
12C-reactive protein is a significant predictor of improved survival in patients with advanced non-small cell lung cancer.
Xiaoguang Xiao,Shujing Wang,Guoxian Long
Medicine.2019;98(26)e16238
[DOI]
13Antitumor activity of interleukin-18 on A549 human lung cancer cell line
Donglan Xiong,Rui Feng,Sheng Yang,Tingyan Lin,Xiangqi Chen
Journal of Cancer Research and Therapeutics.2019;15(7)1635
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal